» Articles » PMID: 17478615

Chronic Obstructive Pulmonary Disease is Associated with Lung Cancer Mortality in a Prospective Study of Never Smokers

Overview
Specialty Critical Care
Date 2007 May 5
PMID 17478615
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Several studies have suggested that previous lung disease may increase the risk of lung cancer. It is important to clarify the association between previous lung disease and lung cancer risk in the general population.

Objectives: The association between self-reported physician-diagnosed chronic bronchitis and emphysema and lung cancer mortality was examined in a U.S. prospective study of 448,600 lifelong nonsmokers who were cancer-free at baseline.

Methods: During the 20-year follow-up period from 1982 to 2002, 1,759 lung cancer deaths occurred. Cox proportional hazards models were used to obtain adjusted hazard ratios (HRs) for lung cancer mortality associated with chronic bronchitis and emphysema as well as for both of these diseases together.

Measurements And Main Results: Lung cancer mortality was significantly associated with both emphysema (HR, 1.66; 95% confidence interval [CI], 1.06, 2.59) and with the combined endpoint of emphysema and chronic bronchitis (HR, 2.44; 95% CI, 1.22, 4.90) in analyses that combined men and women. No association was observed with chronic bronchitis alone (HR, 0.96; 95% CI, 0.72, 1.28) in the overall analysis, although the association was stronger in men (HR, 1.59; 95% CI, 0.95, 2.66) than women (HR, 0.82; 95% CI, 0.58, 1.16; p for interaction, 0.04). The association between emphysema and lung cancer was stronger in analyses that excluded early years of follow-up.

Conclusions: This large prospective study strengthens the evidence that increased lung cancer risk is associated with nonmalignant pulmonary conditions, especially emphysema, even in lifelong nonsmokers.

Citing Articles

Diagnosis and management of comorbid disease in COPD.

Cronin E, Cushen B Breathe (Sheff). 2025; 21(1):240099.

PMID: 40007528 PMC: 11851148. DOI: 10.1183/20734735.0099-2024.


Improved prognostication of overall survival after radiotherapy in lung cancer patients by an interpretable machine learning model integrating lung and tumor radiomics and clinical parameters.

Luo T, Yan M, Zhou M, Dekker A, Appelt A, Ji Y Radiol Med. 2024; 130(1):96-109.

PMID: 39542968 DOI: 10.1007/s11547-024-01919-3.


The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study.

Park J, Lee E, Singh D, Kim E, Park B, Park J Respir Res. 2024; 25(1):229.

PMID: 38822332 PMC: 11140980. DOI: 10.1186/s12931-024-02838-7.


Association of Lung Cancer Risk With the Presence of Both Lung Nodules and Emphysema in a Lung Cancer Screening Trial.

Liu Y, Feng Z, Liu X, Duan H, Lyu Z, Huang Y World J Oncol. 2024; 15(2):246-256.

PMID: 38545483 PMC: 10965254. DOI: 10.14740/wjon1782.


Machine learning model for circulating tumor DNA detection in chronic obstructive pulmonary disease patients with lung cancer.

Shin S, Cha S, Lee H, Shin S, Kim Y, Park D Transl Lung Cancer Res. 2024; 13(1):112-125.

PMID: 38404987 PMC: 10891398. DOI: 10.21037/tlcr-23-633.